MIR4435-2HG: A Crucial Component in New lncRNA Prognostic Signatures Linked to Early Metastasis and Adverse Outcomes Following Tumor Resection in Esophageal Squamous Cell Carcinoma - Top-Institutions - MDSpire

MIR4435-2HG: A Crucial Component in New lncRNA Prognostic Signatures Linked to Early Metastasis and Adverse Outcomes Following Tumor Resection in Esophageal Squamous Cell Carcinoma

  • By

  • Pengju Qi

  • Shuhua Huo

  • Wenchao Wu

  • Tengfei Zhang

  • Wenqian Yang

  • Jiaping Tang

  • Yuzhen Liu

  • Baosheng Zhao

  • November 24, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Molecular Oncology
    • Esophageal Cancer Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Surgical Oncology
    • Cancer Genomics
    • Esophageal Cancer

  • #3

    Fudan University Shanghai Cancer Center
    Fudan University Shanghai Cancer Center

    Shanghai, Shanghai

    Key Differentiators

    • Oncology
    • Molecular Biology
    • Esophageal Squamous Cell Carcinoma

  • #4

    The University of Texas Southwestern Medical Center
    The University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Cancer Genomics
    • Molecular Oncology
    • Gastrointestinal Cancers

  • #5

    National Cancer Center Hospital
    National Cancer Center Hospital

    Tokyo, Tokyo

    Key Differentiators

    • Oncology
    • Molecular Pathology
    • Esophageal Cancer

Original Source(s)

MIR4435-2HG: A Crucial Component in New lncRNA Prognostic Signatures Linked to Early Metastasis and Adverse Outcomes Following Tumor Resection in Esophageal Squamous Cell Carcinoma

  • by Pengju Qi, Shuhua Huo, Wenchao Wu, Tengfei Zhang, Wenqian Yang, Jiaping Tang, Yuzhen Liu, Baosheng Zhao

  • November 24, 2025

Related Content

Radiotherapy plus immunotherapy with or without chemotherapy improves survival in elderly esophageal squamous cell carcinoma: a real-world comorbidity-stratified study

Case Report: Long-term survival in advanced PD-L1-high squamous cell lung cancer following severe immune-related cardiotoxicity

Blood Cell Profiles as Predictors of Treatment Response and Outcomes in Neoadjuvant Immunotherapy with Chemotherapy for Esophageal Squamous Cell Carcinoma